Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: Preliminary results

Europace

Volumn 15, Issue 10, 2013, Pages 1475-1481

  Pezzali, Natalia ^a   Curnis, Antonio ^a   Specchia, Claudia ^b   Carubelli, Valentina ^a   Covolo, Loredana ^b   Donato, Francesco ^b   Auricchio, Angelo ^c   Regoli, François ^c   Metra, Marco ^a  

^a University and Civil Hospital of Brescia   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c DIVISION OF CARDIOLOGY   (Switzerland)

Author keywords

Beta adrenergic receptors gene polymorphism; Cardiac resynchronization therapy (CRT); ICD shocks; Left ventricular reverse remodelling

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CONGESTIVE CARDIOMYOPATHY; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOMOZYGOTE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC DYSFUNCTION;

BETA-ADRENERGIC RECEPTORS GENE POLYMORPHISM; CARDIAC RESYNCHRONIZATION THERAPY (CRT); ICD SHOCKS; LEFT VENTRICULAR REVERSE REMODELLING;

AGED; ARRHYTHMIAS, CARDIAC; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY, DILATED; FEMALE; HEART FAILURE; HOMOZYGOTE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECOVERY OF FUNCTION; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84884992990     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut136     Document Type: Article

References (26)

1. Auger D, van Bommel RJ, Bertini M, Delgado V, Ng AC, Ewe SH et al. Prevalence and characteristics of patients with clinical improvement but not significant left ventricular reverse remodeling after cardiac resynchronization therapy.AmHeart J 2010;160: 737-43.
2. Cho H, Barth AS, Tomaselli GF. Basic science of cardiac resynchronization therapy: molecular and electrophysiological mechanisms. Circ Arrhythm Electrophysiol 2012;5: 594-603.
3. Shanks M, Delgado V, Ng ACT, Auger D, Mooyaart EA, Bertini M et al. Clinical and echocardiographic predictors of non response toCRT. AmHeart J 2011;161:552-7.
4. Metra M, Covolo L, Pezzali N, Zacà V, Bugatti S, Lombardi C et al. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of betablockade with carvedilol in patients with chronic heart failure. Cardiovasc Drugs Ther 2010;24:49-60.
5. Chakir K, Daya SK, Aiba T, Tunin RS, Dimaano VL, Abraham TP et al. Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy. Circulation 2009;119:1231-40.
6. Vanderheyden M, Mullens W, Delrue L, Goethals M, Verstreken S, Wijns Wet al. Endomyocardial upregulation of beta1 adrenoreceptor gene expression and myocardial contractile reserve following cardiac resynchronization therapy. J Card Fail 2008;14:172-8.
7. Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J. 2010 Focused update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace 2010;12:1526-36.
8. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al.; Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-69.
9. Covolo L, Gelatti U, Metra M, Nodari S, Piccichè A, PezzaliNet al. Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study. Eur Heart J 2004;25:1534-41.
10. Metra M, Zani C, Covolo L, Nodari S, Pezzali N, Gelatti U et al. Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study. Eur J Heart Fail 2006;8:131-5.
11. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, EctorHet al. Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society ofCardiology. Developed in Collaboration with the European Heart RhythmAssociation. Europace 2007;9:959-98.
12. D'Ascia C, Cittadini A, Monti MG, Riccio G, Saccà L. Effects of biventricular pacing on interstitial remodeling, tumor necrosis factor-alpha expression and apoptotic death in failing human myocardium. Eur Heart J 2006;27:201-6.
13. Auricchio A, Prinzen FW. Non-responders to cardiac resynchronization therapy: the magnitude of the problem and the issues. Circ J 2011;75:521-7.
14. Barsheshet A,Wang PJ, Moss AJ, Solomon SD, Al-Ahmad A, McNitt S et al. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). J Am Coll Cardiol 2011;57:2416-23.
15. Goldenberg I, Moss AJ, Hall WJ, Foster E, Goldberger JJ, Santucci P et al. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011;124:1527-36.
16. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling concepts and clinical implications on behalf of an International Forum on Cardiac Remodeling: a consensus paper from an International Forum on Cardiac Remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 2000;35:569-82.
17. Mason DA, Moore JD, Green SA, Liggett SB. A gain of-function polymorphism in a G-protein coupling domain of the human ß1-adrenergic receptor. J Biol Chem 1999;274:12670-74.
18. Mialet Perez J, Rathz DA, Petrashevskaya NN, Hahn HS,Wagoner LE, Schwartz A et al. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure. Nat Med 2003;9:1300-5.
19. Brodde OE. Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases. Fundam Clin Pharmacol 2008;22:107-25.
20. Leineweber K, Brodde OE. Beta 2 adrenoreceptor polymorphisms: relation between in vitro and in vivo phenotypes. Life Sci 2004;74:2803-14.
21. Vanderheyden M, Mullens W, Delrue L, Goethals M, Verstreken S, WijnsWet al. Endomyocardial upregulation of beta-1 adrenoreceptor gene expression and myocardial contractile reserve following cardiac resynchronization therapy. J Card Fail 2008;14:172-8.
22. Vanderheyden M, Vrints C, Bartunek J. The molecular fingerprint of cardiac dyssynchrony and cardiac resynchronization therapy. Heart Fail Rev 2011;16:227-33.
23. Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med 2002;346:1357-65.
24. DeMaria R, Landolina M, Gasparini M, Schmitz B, Campolo J, ParoliniMet al. Genetic variants of the renin-angiotensin-aldosterone system and reverse remodeling after cardiac resynchronization therapy. J Card Fail 2012;18:762-8.
25. Sotoodehnia N, Siscovick DS, Vatta M, Psaty BM, Tracy RP, Towbin JA et al. Beta2-adrenergic receptor genetic variants and risk of sudden cardiac death. Circulation 2006;113:1842-8.
26. Shin J, Lobmeyer MT, Gong Y, Zineh I, Langaee TY, Yarandi H et al. Relation of beta(2)-adrenoreceptor haplotype to risk of death and heart transplantation in patients with heart failure. Am J Cardiol 2007;99:250-5.